167 related articles for article (PubMed ID: 26442588)
1. Tumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular Carcinoma.
Liu W; Liu Y; Liu H; Zhang W; Fu Q; Xu J; Gu J
J Biol Chem; 2015 Nov; 290(47):28489-28501. PubMed ID: 26442588
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of p21-activated kinase 6 in hepatocellular carcinoma.
Chen H; Miao J; Li H; Wang C; Li J; Zhu Y; Wang J; Wu X; Qiao H
J Surg Res; 2014 Jun; 189(1):81-8. PubMed ID: 24576777
[TBL] [Abstract][Full Text] [Related]
3. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
4. p21-activated kinase 6 controls mitosis and hepatocellular carcinoma progression by regulating Eg5.
Zheng J; Zhang C; Li Y; Jiang Y; Xing B; Du X
Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118888. PubMed ID: 33098954
[TBL] [Abstract][Full Text] [Related]
5. Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma.
Chen L; Liu H; Liu J; Zhu Y; Xu L; He H; Zhang H; Wang S; Wu Q; Liu W; Liu Y; Pan D; Ren S; Xu J; Gu J
PLoS One; 2013; 8(3):e58413. PubMed ID: 23516476
[TBL] [Abstract][Full Text] [Related]
6. N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation.
Liu J; Liu H; Zhang W; Wu Q; Liu W; Liu Y; Pan D; Xu J; Gu J
Glycobiology; 2013 Sep; 23(9):1097-109. PubMed ID: 23811795
[TBL] [Abstract][Full Text] [Related]
7. DNMT1 modulates interneuron morphology by regulating Pak6 expression through crosstalk with histone modifications.
Symmank J; Bayer C; Schmidt C; Hahn A; Pensold D; Zimmer-Bensch G
Epigenetics; 2018; 13(5):536-556. PubMed ID: 29912614
[TBL] [Abstract][Full Text] [Related]
8. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
[TBL] [Abstract][Full Text] [Related]
9. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
[TBL] [Abstract][Full Text] [Related]
10. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.
Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X
Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742
[TBL] [Abstract][Full Text] [Related]
11. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.
Lu SX; Zhang CZ; Luo RZ; Wang CH; Liu LL; Fu J; Zhang L; Wang H; Xie D; Yun JP
Cancer Lett; 2017 Aug; 402():71-80. PubMed ID: 28577975
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
13. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
14. PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy.
Chen J; Lu H; Yan D; Cui F; Wang X; Yu F; Xue Y; Feng X; Wang J; Wang X; Jiang T; Zhang M; Zhao S; Yu Y; Tang H; Peng Z
Oncotarget; 2015 Jan; 6(1):355-67. PubMed ID: 25426562
[TBL] [Abstract][Full Text] [Related]
15. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
[TBL] [Abstract][Full Text] [Related]
16. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
18. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
20. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.
Li Y; Zuo H; Wang H; Hu A
Biomed Pharmacother; 2019 Aug; 116():108749. PubMed ID: 31071576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
